Immediate Impact

58 standout
Sub-graph 1 of 23

Citing Papers

Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs
2024 Standout
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
2 intermediate papers

Works of Ryan J. Ice being referenced

Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
2020
Durable multitransgene expression in vivo using systemic, nonviral DNA delivery
2019

Author Peers

Author Last Decade Papers Cites
Ryan J. Ice 91 176 90 14 282
María del Mar Maldonado 87 220 75 13 321
Shunsuke Ebara 68 202 63 11 318
Romain M. Larive 85 226 40 17 313
Chengyao Xie 98 246 80 18 335
Μαργαρίτα Λάμπρου 31 159 77 18 309
Cheng‐Hao Chuang 97 120 36 17 252
Yi Hong 98 212 43 18 332
Dorota Ciołczyk-Wierzbicka 69 240 58 21 312
Florian Bonin 110 153 42 11 284
Sela T. Po’uha 77 204 184 10 335

All Works

Loading papers...

Rankless by CCL
2026